GE HealthCare Technologies Inc. (NASDAQ:GEHC) Receives Consensus Recommendation of “Moderate Buy” from Analysts

Shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) have received an average recommendation of “Moderate Buy” from the eighteen research firms that are presently covering the firm, Marketbeat reports. Nine equities research analysts have rated the stock with a hold rating and nine have given a buy rating to the company. The average 1 year price objective among brokerages that have covered the stock in the last year is $80.2105.

A number of research analysts have recently weighed in on the company. JPMorgan Chase & Co. dropped their price target on GE HealthCare Technologies from $80.00 to $65.00 and set a “neutral” rating for the company in a research report on Thursday, April 30th. Wells Fargo & Company dropped their price target on GE HealthCare Technologies from $97.00 to $75.00 and set an “overweight” rating for the company in a research report on Thursday, April 30th. Mizuho dropped their price target on GE HealthCare Technologies from $90.00 to $80.00 in a research report on Thursday, April 30th. Oppenheimer restated an “outperform” rating and issued a $85.00 price target on shares of GE HealthCare Technologies in a research report on Thursday, April 30th. Finally, BNP Paribas Exane dropped their price target on GE HealthCare Technologies from $95.00 to $88.00 in a research report on Friday, May 1st.

GE HealthCare Technologies Trading Up 1.2%

Shares of GEHC stock opened at $64.51 on Friday. GE HealthCare Technologies has a fifty-two week low of $58.75 and a fifty-two week high of $89.77. The stock has a market cap of $29.34 billion, a P/E ratio of 15.43, a P/E/G ratio of 1.44 and a beta of 0.74. The business has a fifty day simple moving average of $66.46 and a 200-day simple moving average of $75.27. The company has a quick ratio of 0.95, a current ratio of 1.22 and a debt-to-equity ratio of 0.95.

GE HealthCare Technologies (NASDAQ:GEHC) last announced its quarterly earnings results on Wednesday, April 29th. The company reported $0.99 earnings per share for the quarter, missing analysts’ consensus estimates of $1.07 by ($0.08). GE HealthCare Technologies had a net margin of 9.10% and a return on equity of 20.46%. The firm had revenue of $5.13 billion during the quarter, compared to analysts’ expectations of $5.04 billion. During the same quarter in the prior year, the business earned $1.01 EPS. The company’s quarterly revenue was up 7.4% compared to the same quarter last year. GE HealthCare Technologies has set its FY 2026 guidance at 4.800-5.000 EPS. On average, analysts forecast that GE HealthCare Technologies will post 4.89 earnings per share for the current fiscal year.

Insider Buying and Selling at GE HealthCare Technologies

In related news, Director Rodney F. Hochman acquired 1,618 shares of the firm’s stock in a transaction that occurred on Tuesday, May 12th. The shares were acquired at an average price of $62.03 per share, with a total value of $100,364.54. Following the completion of the purchase, the director directly owned 1,618 shares in the company, valued at approximately $100,364.54. The trade was a ∞ increase in their ownership of the stock. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, CFO James Saccaro acquired 3,310 shares of the firm’s stock in a transaction that occurred on Friday, May 1st. The shares were bought at an average cost of $60.60 per share, for a total transaction of $200,586.00. Following the purchase, the chief financial officer owned 87,471 shares of the company’s stock, valued at approximately $5,300,742.60. The trade was a 3.93% increase in their ownership of the stock. Additional details regarding this purchase are available in the official SEC disclosure. Over the last quarter, insiders have acquired 21,847 shares of company stock valued at $1,361,355. 0.36% of the stock is owned by company insiders.

Institutional Trading of GE HealthCare Technologies

Large investors have recently made changes to their positions in the stock. Laurel Wealth Advisors LLC acquired a new stake in shares of GE HealthCare Technologies during the fourth quarter valued at $26,000. Optima Capital LLC acquired a new stake in GE HealthCare Technologies in the 4th quarter worth about $27,000. Godfrey Financial Associates Inc. purchased a new stake in GE HealthCare Technologies in the 4th quarter valued at about $27,000. Montag A & Associates Inc. grew its holdings in GE HealthCare Technologies by 105.4% in the 4th quarter. Montag A & Associates Inc. now owns 341 shares of the company’s stock valued at $28,000 after buying an additional 175 shares during the period. Finally, Transamerica Financial Advisors LLC grew its holdings in GE HealthCare Technologies by 331.6% in the 4th quarter. Transamerica Financial Advisors LLC now owns 341 shares of the company’s stock valued at $28,000 after buying an additional 262 shares during the period. Institutional investors and hedge funds own 82.06% of the company’s stock.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.